DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Dadu R, Shah K, Busaidy NL. et al.
Efficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive
papillary thyroid cancer: M.D. Anderson Cancer Center off-label experience.
J Clin Endocrinol Metab 2015;
100: E77-81
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.